Group | MAP | BW | LVW | AAR | Infarct Size | Mortality |
---|---|---|---|---|---|---|
mm Hg | g | mg | % of LVW | % of AAR | % | |
Sham (n = 10) | 97 ± 5 | 310 ± 12 | 522 ± 32 | 0 | ||
Vehicle + MI/R (n = 14) | 100 ± 3 | 306 ± 9 | 508 ± 23 | 53.8 ± 2.6 | 54.7 ± 2.0 | 29 |
NCX + MI/R (n = 10) | 98 ± 4 | 308 ± 7 | 514 ± 21 | 52.2 ± 1.6 | 24.5 ± 3.65-165 | 0 |
L-NAME + MI/R (n = 18) | 142 ± 55-160 | 305 ± 8 | 503 ± 30 | 54.4 ± 2.8 | 68.2 ± 1.55-150 | 44 |
NCX + l-NAME + MI/R (n = 11) | 107 ± 45-a | 307 ± 13 | 519 ± 25 | 52.7 ± 3.4 | 33.9 ± 2.35-150 5-b | 9 |
Drugs and vehicle (2 ml/kg PEG 400) were given orally for 5 consecutive days. Data are expressed as mean ± S.E. In parentheses, number of experiments. Sham-operated animals were treated with vehicle.